Replies to post #3200 on GTC Biotherapeutics (fka GTCB)

[floblu14]

>Is it your understanding that phase-2 MM-093 data will still be reported at EULAR?<

Dew - I did not ask that question - but there should be a press release within a few weeks.

As mentioned, the contact was quite upbeat & felt the additional MG would bring a successful end result

Cesrph09 - The FDA approved this 3 month trial with the added dosage. There was "NO SAFETY PROBLEM." FWIW & IMHO the FDA had the data & decided to let them proceed. We'll know something shortly.